share_log

JP Morgan Maintains Overweight on Sage Therapeutics, Raises Price Target to $29

Moomoo 24/7 ·  Mar 26 06:21

JP Morgan analyst Anupam Rama maintains Sage Therapeutics (NASDAQ:SAGE) with a Overweight and raises the price target from $24 to $29.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment